Matches in Wikidata for { <http://www.wikidata.org/entity/Q70186338> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q70186338 description "article scientifique publié en 1987" @default.
- Q70186338 description "artículu científicu espublizáu en xunetu de 1987" @default.
- Q70186338 description "im Juli 1987 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70186338 description "scientific article published on 01 July 1987" @default.
- Q70186338 description "wetenschappelijk artikel" @default.
- Q70186338 description "наукова стаття, опублікована в липні 1987" @default.
- Q70186338 name "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 name "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 type Item @default.
- Q70186338 label "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 label "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 prefLabel "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 prefLabel "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 P1433 Q70186338-042D19BE-09BB-4D34-9018-AB619F40D7E2 @default.
- Q70186338 P1476 Q70186338-797D9E64-CBD6-4D5F-AA99-EA50A0B3DCBD @default.
- Q70186338 P2093 Q70186338-0D8A7EE0-ED94-474E-9E38-FF9957F20B7F @default.
- Q70186338 P2093 Q70186338-2D471B3B-4753-400C-9D23-201552CD498C @default.
- Q70186338 P2093 Q70186338-409E0567-8178-49AD-8514-63BE97EC5E98 @default.
- Q70186338 P2093 Q70186338-609F66A7-7437-44B3-B342-B11376561856 @default.
- Q70186338 P2093 Q70186338-6D40AC41-254D-4FFE-B287-CC956A225028 @default.
- Q70186338 P2093 Q70186338-C8EC1A72-B279-40C7-B1EA-9C1550DF85B8 @default.
- Q70186338 P2093 Q70186338-D63D7C54-50A4-48B2-9014-5748FF5A062F @default.
- Q70186338 P304 Q70186338-F3DE5872-2D0B-46A2-ACEF-11F9869632A6 @default.
- Q70186338 P31 Q70186338-C5CCE394-1E49-45B1-BD98-21B627FF2904 @default.
- Q70186338 P433 Q70186338-DAE4E03A-DFB0-4F2E-86DE-7BAA9A448FDA @default.
- Q70186338 P478 Q70186338-7A1D2947-E35B-4A1F-950B-330D98BC3740 @default.
- Q70186338 P577 Q70186338-6823E862-CCA7-4CDB-A616-EEEF0FE6EAB2 @default.
- Q70186338 P698 Q70186338-FD4A4A89-4006-4E6E-9179-63AE2B39F25E @default.
- Q70186338 P921 Q70186338-597A48C5-EF2C-482D-869B-298D176C8662 @default.
- Q70186338 P921 Q70186338-D95FF9FA-8BAF-4133-9D53-14A6BE818B2B @default.
- Q70186338 P698 3038319 @default.
- Q70186338 P1433 Q27710285 @default.
- Q70186338 P1476 "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer" @default.
- Q70186338 P2093 "Burke MT" @default.
- Q70186338 P2093 "Fiore JJ" @default.
- Q70186338 P2093 "Gralla RJ" @default.
- Q70186338 P2093 "Heelan RT" @default.
- Q70186338 P2093 "Kelsen DP" @default.
- Q70186338 P2093 "Kris MG" @default.
- Q70186338 P2093 "Marks LD" @default.
- Q70186338 P304 "783-784" @default.
- Q70186338 P31 Q13442814 @default.
- Q70186338 P433 "7-8" @default.
- Q70186338 P478 "71" @default.
- Q70186338 P577 "1987-07-01T00:00:00Z" @default.
- Q70186338 P698 "3038319" @default.
- Q70186338 P921 Q3658562 @default.
- Q70186338 P921 Q42824440 @default.